These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17371733)

  • 1. The gadolinium complexes with polyoxometalates as potential MRI contrast agents.
    Li Z; Li W; Li X; Pei F; Li Y; Lei H
    Magn Reson Imaging; 2007 Apr; 25(3):412-7. PubMed ID: 17371733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of sandwiched gadolinium (III) complexes with tungstosilicates as potential MRI contrast agents.
    Sun G; Feng J; Wu H; Pei F; Fang K; Lei H
    Magn Reson Imaging; 2004 Apr; 22(3):421-6. PubMed ID: 15062939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of gadolinium polyoxometalates as possible MRI contrast agent.
    Feng J; Li X; Pei F; Sun G; Zhang X; Liu M
    Magn Reson Imaging; 2002 Jun; 20(5):407-12. PubMed ID: 12206866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between GdDTPA and two gadolinium polyoxometalates as potential MRI contrast agents.
    Feng J; Sun G; Pei F; Liu M
    J Inorg Biochem; 2002 Nov; 92(3-4):193-9. PubMed ID: 12433428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mn(II)-monosubstituted polyoxometalates as candidates for contrast agents in magnetic resonance imaging.
    Li Z; Li W; Li X; Pei F; Wang X; Lei H
    J Inorg Biochem; 2007 Jul; 101(7):1036-42. PubMed ID: 17524483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
    Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
    Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo MRI assessment of a novel GdIII-based contrast agent designed for high magnetic field applications.
    de Sousa PL; Livramento JB; Helm L; Merbach AE; Même W; Doan BT; Beloeil JC; Prata MI; Santos AC; Geraldes CF; Tóth E
    Contrast Media Mol Imaging; 2008; 3(2):78-85. PubMed ID: 18412106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
    Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
    Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography?
    Yu G; Yamashita M; Aoshima K; Takahashi M; Oshikawa T; Takayanagi H; Laurent S; Burtea C; Vander Elst L; Muller RN
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2246-9. PubMed ID: 17303417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes.
    Zong Y; Guo J; Ke T; Mohs AM; Parker DL; Lu ZR
    J Control Release; 2006 May; 112(3):350-6. PubMed ID: 16631270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.
    Luo K; Liu G; She W; Wang Q; Wang G; He B; Ai H; Gong Q; Song B; Gu Z
    Biomaterials; 2011 Nov; 32(31):7951-60. PubMed ID: 21784511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
    Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K
    Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
    J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging.
    Langereis S; de Lussanet QG; van Genderen MH; Meijer EW; Beets-Tan RG; Griffioen AW; van Engelshoven JM; Backes WH
    NMR Biomed; 2006 Feb; 19(1):133-41. PubMed ID: 16450331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evaluation of gadolinium hydroxypyridonate chelates: initial experience as contrast media in magnetic resonance imaging.
    Thompson MK; Misselwitz B; Tso LS; Doble DM; Schmitt-Willich H; Raymond KN
    J Med Chem; 2005 Jun; 48(11):3874-7. PubMed ID: 15916439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.
    Peller M; Schwerdt A; Hossann M; Reinl HM; Wang T; Sourbron S; Ogris M; Lindner LH
    Invest Radiol; 2008 Dec; 43(12):877-92. PubMed ID: 19002060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.
    Zhu D; Lu X; Hardy PA; Leggas M; Jay M
    Invest Radiol; 2008 Feb; 43(2):129-40. PubMed ID: 18197065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.